Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Matucci

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
Expert Opinion on Drug Safety|December 8, 2016
Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysisStefanos Bonovas, Silvia Minozzi, Theodore Lytras, et al.
Vaccine|June 6, 2025
A real-life multicenter experience for the post-pandemic management of hypersensitivity reactions to Covid-19 vaccinesAlessandra Arcolaci, Lucia Guidolin, Elisa Olivieri, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 1, 2022
High proportion of inflammatory CD62L<sup>low</sup> eosinophils in blood and nasal polyps of severe asthma patientsAndrea Matucci, Francesca Nencini, Giandomenico Maggiore, et al.
International Immunopharmacology|November 2, 2017
Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42]Giuseppe Spadaro, Alessandra Vultaggio, Alberto Bosi, et al.
International Immunopharmacology|January 11, 2017
Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopeniaGiuseppe Spadaro, Alessandra Vultaggio, A Alberto Bosi, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 13, 2024
Asthma remission one, none and one-hundred thousand: the relevance of the patient's viewMatteo Bonini, Simona Barbaglia, Gianna Camiciottoli, et al.
Mayo Clinic Proceedings|September 20, 2021
Eosinophils in Health and Disease: A State-of-the-Art ReviewMichael E Wechsler, Ariel Munitz, Steven J Ackerman, et al.
Respiratory Medicine|December 1, 2020
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severityMarco Caminati, Alessandra Vultaggio, Andrea Matucci, et al.
Expert Opinion on Drug Safety|December 8, 2016
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysisSilvia Minozzi, Stefanos Bonovas, Theodore Lytras, et al.
The Journal of Allergy and Clinical Immunology|March 27, 2019
Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficienciesCinzia Milito, Federica Pulvirenti, Francesco Cinetto, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Expert Opinion on Drug Safety|December 8, 2016
Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysisStefanos Bonovas, Silvia Minozzi, Theodore Lytras, et al.
Vaccine|June 6, 2025
A real-life multicenter experience for the post-pandemic management of hypersensitivity reactions to Covid-19 vaccinesAlessandra Arcolaci, Lucia Guidolin, Elisa Olivieri, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 1, 2022
High proportion of inflammatory CD62L<sup>low</sup> eosinophils in blood and nasal polyps of severe asthma patientsAndrea Matucci, Francesca Nencini, Giandomenico Maggiore, et al.
International Immunopharmacology|November 2, 2017
Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42]Giuseppe Spadaro, Alessandra Vultaggio, Alberto Bosi, et al.
International Immunopharmacology|January 11, 2017
Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopeniaGiuseppe Spadaro, Alessandra Vultaggio, A Alberto Bosi, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 13, 2024
Asthma remission one, none and one-hundred thousand: the relevance of the patient's viewMatteo Bonini, Simona Barbaglia, Gianna Camiciottoli, et al.
Mayo Clinic Proceedings|September 20, 2021
Eosinophils in Health and Disease: A State-of-the-Art ReviewMichael E Wechsler, Ariel Munitz, Steven J Ackerman, et al.
Respiratory Medicine|December 1, 2020
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severityMarco Caminati, Alessandra Vultaggio, Andrea Matucci, et al.
Expert Opinion on Drug Safety|December 8, 2016
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysisSilvia Minozzi, Stefanos Bonovas, Theodore Lytras, et al.
The Journal of Allergy and Clinical Immunology|March 27, 2019
Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficienciesCinzia Milito, Federica Pulvirenti, Francesco Cinetto, et al.
Pageof 16